Abiopharma

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025

FDA Issues Complete Response Letter for Biohavens VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®

Pennant Acquires Senior Living Communities in Idaho and Wisconsin

Westlake kondigt openbaar bod in contanten aan

Westlake annonce une offre publique envisagée de billets de premier rang

FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation

Pacific Health Care Organization, Inc. Reports its Third Quarter 2025 Financial Results

Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025

Travere Therapeutics to Participate at Upcoming Investor Conferences